[{"Assets_0_Q1_USD":28343807.0,"CommonStockSharesOutstanding_0_Q1_shares":44421992.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-3620133.0,"NetIncomeLoss_1_Q1_USD":-4059165.0,"StockholdersEquity_0_Q1_USD":25545335.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20171231","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180207"}]